Neuronetics is trading at $2.57, up 5.76% in pre-market, with no confirmed company-specific catalyst for the move.

  • No new company-specific explanation for the November 6 pre-market move surfaced in the search.
  • The clearest recent company news was its November 4 Q3 report: revenue beat estimates, losses narrowed, and management raised the low end of its gross-margin outlook.
  • The report preceded the November 5 close; mixed market context does not confirm a direct market or company catalyst.